Enerflex (TSE:EFX – Free Report) had its target price raised by BMO Capital Markets from C$11.00 to C$15.00 in a report ...

Equifax (EFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

On Friday, Equifax Inc (EFX) stock saw a decline, ending the day at $248.27 which represents a decrease of $-13.94 or -5.32% from the prior close of $262.21. The stock opened at $257.81 and touched a ...

RBC Capital analyst Keith Mackey maintained a Buy rating on Enerflex (EFX – Research Report) today and set a price target of $12.00. The ...

Enerflex (TSE:EFX – Free Report) had its target price increased by Acumen Capital from C$12.00 to C$15.00 in a research report released on Friday morning,BayStreet.CA reports. Several other brokerages ...

The use of AI-based digital pathology further corroborates the efficacy of EFX, with a high percentage of patients experiencing improvements in liver stiffness and fibrosis scores over a 96-week ...

The study revealed that after 96 weeks of EFX treatment, over 40% of participants exhibited regression of liver fibrosis, a key indicator of MASH progression. This includes improvements in liver ...

SOUTH SAN FRANCISCO - Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage biotechnology company, announced significant clinical outcomes from its Phase 2b HARMONY study, evaluating the efficacy ...

Celebrities having birthdays during the week of Nov. 24-30 include “The Daily Show” host Jon Stewart, singer Billy Idol and ...

In the latest quarter, 11 analysts provided ratings for Equifax EFX, showcasing a mix of bullish and bearish perspectives.